UNSPSC 51412801: Etafenone

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0I14K589E7. European Medicines Agency schedules Etafenone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07257MIG. Etafenone generally arises in the molecular formula C21H27NO2.

UNSPSC 51412801 Etafenone is a Commodity code for a specific pharmaceutical active ingredient, but state and local procurement activity under this code shows minimal relevant recent solicitation. The City of Tampa posted a sealed-bid opportunity (26P00188) in April 2026 for Advanced Life Support Medications for Tampa Fire Rescue that included four specific drug formulations — Labetalol HCI, Epinephrine, Adenosine, and Diltiazem — none of which is etafenone. The opportunity was tagged under this code despite the mismatch between the code's nominal scope and the medications actually being solicited. State and local health-care purchasing, particularly for emergency medical services, typically consolidates pharmaceutical procurements under broader drug-class or clinical-category codes rather than discrete active-ingredient codes.

The Tampa Fire Rescue opportunity represents the only recent state and local activity visible under this code. The solicitation (due April 8, 2026, with an estimated contract value of $40,000) included a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount capped at $10,000 and required vendors to supply medications with a minimum nine-month expiration date and deliver within ten calendar days. The contract term ran one year from award with two one-year renewal options plus three additional 30-day periods at the city's option. No standout repeat buyers or broader geographic activity under this code appears in recent state and local procurement records. Activity levels suggest this code sees limited use for state and local solicitation purposes; business-development focus on pharmaceutical supply to emergency services and health agencies would be better directed to higher-tier family or class codes covering broad emergency medical supply categories rather than individual active-ingredient commodities.